跳至主要内容
临床试验/EUCTR2009-018266-35-BE
EUCTR2009-018266-35-BE进行中(未招募)1 期

Efficacy of rituximab for the treatment of calcineurin inhibitors dependant nephrotic syndrome during childhood - NEPHRUTIX

CHU de LIMOGES0 个研究点目标入组 26 人开始时间: 2013年6月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - 2 to 18 years old
  • - idiopathic steroid dependent and calcineurin inhibitors dependant nephrotic syndrome
  • - nephrotic relapse during the last 6 months
  • - patient in remission at inclusion
  • - effective contraception for female of child bearing potential
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 26
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - end stage renal failure
  • - rituximab contre-indication
  • - transcutaneous oxygen saturation < 97%
  • - pleural pulmonary or bronchus lesion
  • - hepatitis B carrier or medical history of hepatitis B
  • - patient or parents refusing to participate into the study

研究者

发起方
CHU de LIMOGES

相似试验